Mesogastrium Metastasis in Colon Cancer
Right Gastroepiploic Mesentery Metastasis in Advanced Colon Cancer Locating at or Close to the Hepatic Flexure
Jichao Qin
50 participants
Jan 12, 2021
OBSERVATIONAL
Conditions
Summary
Complete mesocolic excision is currently recognized as a standard procedure for colon cancer. Controversy remains on the presence of right gastroepiploic mesentery metastasis in patients with colon cancer locating at or close to the hepatic flexure. The investigators design this study in order to define the incidence of mesogastrium metastasis and analyse the safety and surgical outcome in these patients who undergo complete mesocolic excision with right gastroepiploic mesentery resection.
Eligibility
Inclusion Criteria7
- Age between 18 and 75 years
- American Society of Anesthesiologists (ASA) score I to III
- A biopsy proven histological diagnosis of colorectal carcinoma
- Preoperative staging cT2-4aN0M0 or cTanyN+M0
- tumor located at hepatic flexure or transverse colon close to flexures
- Undergoing complete mesocolic excision with right gastric mesentery resection
- Patients have to be aware of the aim of the trial, and have signed the informed consent.
Exclusion Criteria5
- Synchronous colorectal carcinoma
- Clinical evidence of metastasis
- History of colorectal cancer or other malignant tumors
- Preoperative staging cT1N0 or cT4bNany
- Emergency procedure
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04980287